Ari Raved serves as Executive at AIT Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ari Raved has executed 2 insider transactions totaling $236.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 22, 2018 involved selling 74,000 shares valued at $236.8K.
Ari Raved currently holds 565,885 shares of AIT Therapeutics, Inc. (AITB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ari Raved has been a net seller of AITB stock. They have purchased $0 and sold $236.8K worth of shares.
Ari Raved's most recent insider trade was on Jun 22, 2018, when they sold 74,000 shares at $3.20 per share.
Get notified when new Form 4 filings are submitted
| $4.25 |
| Discretionary |